93 related articles for article (PubMed ID: 33504439)
1. Inhibition of the Epigenetic Reader BRD4 Reduces SIRPα-Mediated Phagocytosis and Melanoma Invasion.
Scheeren FA; van Doorn R
J Invest Dermatol; 2021 Feb; 141(2):252-254. PubMed ID: 33504439
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer.
Hong SH; Eun JW; Choi SK; Shen Q; Choi WS; Han JW; Nam SW; You JS
Oncotarget; 2016 May; 7(22):32628-40. PubMed ID: 27081696
[TBL] [Abstract][Full Text] [Related]
3. Bromodomain Epigenetic Protein Promotes Metastatic Potential in Melanoma Cells through Increased Invasiveness and Decreased Macrophage-Mediated Phagocytosis.
Le K; Matar H; Gupta M
J Invest Dermatol; 2021 Feb; 141(2):454-458.e2. PubMed ID: 32645364
[No Abstract] [Full Text] [Related]
4. A 7-methoxybicoumarin derivative selectively inhibits BRD4 BD2 for anti-melanoma therapy.
Yang GJ; Wang W; Lei PM; Leung CH; Ma DL
Int J Biol Macromol; 2020 Dec; 164():3204-3220. PubMed ID: 32860796
[TBL] [Abstract][Full Text] [Related]
5. BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC.
Ba M; Long H; Yan Z; Wang S; Wu Y; Tu Y; Gong Y; Cui S
J Cell Biochem; 2018 Jan; 119(1):973-982. PubMed ID: 28681984
[TBL] [Abstract][Full Text] [Related]
6. Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer.
Mao F; Li J; Luo Q; Wang R; Kong Y; Carlock C; Liu Z; Elzey BD; Liu X
Mol Cancer Ther; 2018 Jul; 17(7):1554-1565. PubMed ID: 29716963
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulator BRD4 is involved in cadmium-induced acute kidney injury via contributing to lysosomal dysfunction, autophagy blockade and oxidative stress.
Gong ZG; Zhao Y; Wang ZY; Fan RF; Liu ZP; Wang L
J Hazard Mater; 2022 Feb; 423(Pt A):127110. PubMed ID: 34523489
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD.
Zhou X; Fan LX; Peters DJ; Trudel M; Bradner JE; Li X
Hum Mol Genet; 2015 Jul; 24(14):3982-93. PubMed ID: 25877301
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X
Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279
[TBL] [Abstract][Full Text] [Related]
12. BRD4 Promotes Gastric Cancer Progression and Metastasis through Acetylation-Dependent Stabilization of Snail.
Qin ZY; Wang T; Su S; Shen LT; Zhu GX; Liu Q; Zhang L; Liu KW; Zhang Y; Zhou ZH; Zhang XN; Wen LZ; Yao YL; Sun WJ; Guo Y; Liu KJ; Liu L; Wang XW; Wei YL; Wang J; Xiao HL; Liu P; Bian XW; Chen DF; Wang B
Cancer Res; 2019 Oct; 79(19):4869-4881. PubMed ID: 31311807
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of and therapeutic strategies targeting BRD4 in cancer.
White ME; Fenger JM; Carson WE
Cell Immunol; 2019 Mar; 337():48-53. PubMed ID: 30832981
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Suppression of HIV in Myeloid Cells by the BRD4-Selective Small Molecule Modulator ZL0580.
Alamer E; Zhong C; Liu Z; Niu Q; Long F; Guo L; Gelman BB; Soong L; Zhou J; Hu H
J Virol; 2020 May; 94(11):. PubMed ID: 32188727
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a potent, orally available tricyclic derivative as a novel BRD4 inhibitor for melanoma.
Horai Y; Suda N; Uchihashi S; Katakuse M; Shigeno T; Hirano T; Takahara J; Fujita T; Mukoyama Y; Haga Y
Bioorg Med Chem; 2023 Oct; 93():117461. PubMed ID: 37659219
[TBL] [Abstract][Full Text] [Related]
16. Chromatin Landscape of the IRF Genes and Role of the Epigenetic Reader BRD4.
Bachu M; Dey A; Ozato K
J Interferon Cytokine Res; 2016 Jul; 36(7):470-5. PubMed ID: 27379869
[TBL] [Abstract][Full Text] [Related]
17. The epigenetic reader Brd4 is required for osteoblast differentiation.
Paradise CR; Galvan ML; Kubrova E; Bowden S; Liu E; Carstens MF; Thaler R; Stein GS; van Wijnen AJ; Dudakovic A
J Cell Physiol; 2020 Jun; 235(6):5293-5304. PubMed ID: 31868237
[TBL] [Abstract][Full Text] [Related]
18. Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma.
Wang R; Cao XJ; Kulej K; Liu W; Ma T; MacDonald M; Chiang CM; Garcia BA; You J
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5352-E5361. PubMed ID: 28630312
[TBL] [Abstract][Full Text] [Related]
19. Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression.
Zhou B; Mu J; Gong Y; Lu C; Zhao Y; He T; Qin Z
Redox Biol; 2017 Apr; 11():390-402. PubMed ID: 28063381
[TBL] [Abstract][Full Text] [Related]
20. The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.
Wollebo HS; Bellizzi A; Cossari DH; Salkind J; Safak M; White MK
J Neurovirol; 2016 Oct; 22(5):615-625. PubMed ID: 27007123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
